HRS-1893
Sponsors
Shandong Suncadia Medicine Co., Ltd., Atridia Pty Ltd.
Conditions
Hypertrophic CardiomyopathyNon-obstructive Hypertrophic CardiomyopathyObstructive Hypertrophic Cardiomyopathy
Early Phase 1
Phase 1
A Trial of HRS-1893 in Healthy Volunteers and Patients With Obstructive Hypertrophic Cardiomyopathy
CompletedNCT05879523
Start: 2023-06-05End: 2024-03-21Updated: 2024-10-30
Safety and Pharmacokinetics Study of HRS-1893 Tablets in Healthy Subjects and Those With Impaired Kidney Function
CompletedNCT06775834
Start: 2025-02-11End: 2025-07-23Updated: 2025-09-10
Phase 2
A Trial of HRS-1893 in Patients With Obstructive Hypertrophic Cardiomyopathy
Active, not recruitingNCT06516068
Start: 2024-08-11End: 2025-08-31Updated: 2025-07-16
A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy
CompletedNCT06816251
Start: 2025-02-25End: 2025-11-18Updated: 2026-08-24